Takeda Pharmaceutical Co Ltd
DUS:TKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
DUS:TKD
|
JP |
|
C
|
Curtiss-Wright Corp
F:CWT
|
US |
|
T
|
Teijin Ltd
F:TIJ
|
JP |
|
Univest Financial Corp
F:UVE
|
US |
|
AVITA Medical Inc
NASDAQ:RCEL
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
XBER:TKD
|
JP |
|
S
|
Serco Group PLC
DUS:SEO
|
UK |
|
T
|
Talisker Resources Ltd
OTC:TSKFF
|
CA |
|
Y
|
Yeti Holdings Inc
F:1YN
|
US |
|
R
|
Rexel SA
XMUN:E7V
|
FR |
|
S
|
Serco Group PLC
OTC:SECCF
|
UK |
|
Acousort AB
F:4SA
|
SE |
|
Bumi Resources Minerals Tbk PT
F:BUR
|
ID |
|
Surefire Resources NL
ASX:SRN
|
AU |
|
A
|
Adecoagro SA
SWB:ACD
|
LU |
|
T
|
Teijin Ltd
DUS:TIJ
|
JP |
Wall St Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKD is 29.18 EUR with a low forecast of 24.26 EUR and a high forecast of 38.32 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKD's stock price target?
Price Target
29.18
EUR
According to Wall Street analysts, the average 1-year price target for TKD is 29.18 EUR with a low forecast of 24.26 EUR and a high forecast of 38.32 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 1 year is -24%.
